Colin Sullivan has made significant contributions internationally to the understanding and treatment of sleep apnea. He was not only instrumental in developing the first adult and paediatric sleep laboratories in Australia, he also invented the nasal CPAP technology used to treat sleep apnea. Colin is known internationally for the use of nasal continuous positive airway pressure, for treating obstructive sleep apnea, and has played a direct role in the development of the Australian company ResMed that now produces and exports these devices. Colin has continued his efforts to repeat the success ResMed by developing a centre linked with the University to act as an incubator for developing medical technology. Further to his professorial role, at present, Colin is Chair of the Research Committee in the Department of Medicine at the University of Sydney, and a Consultant Physician with the Children’s Hospital at Westmead and the Sydney Children’s Hospital in Randwick.